Dr. Reddy's Laboratories, Ltd. v. Takeda Pharmaceuticals U.S.A., Inc.
Plaintiff: Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Defendant: Takeda Pharmaceuticals U.S.A., Inc.
Case Number: 1:2020cv00792
Filed: June 11, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Contract: Other
Cause of Action: 28 U.S.C. § 1332
Jury Demanded By: None
Docket Report

This docket was last retrieved on August 7, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 7, 2020 Filing 16 REQUEST for Oral Argument by Takeda Pharmaceuticals U.S.A., Inc. re #8 MOTION to Dismiss for Lack of Subject Matter Jurisdiction or, in the Alternative, Under the Two Dismissal Rule. (Rahmeier, Thatcher)
August 7, 2020 Filing 15 REPLY BRIEF re #8 MOTION to Dismiss for Lack of Subject Matter Jurisdiction or, in the Alternative, Under the Two Dismissal Rule filed by Takeda Pharmaceuticals U.S.A., Inc.. (Rahmeier, Thatcher)
August 3, 2020 Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: #1 Certification)(Brauerman, Stephen) Modified on 8/3/2020 (nms).
August 3, 2020 Opinion or Order SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Lana S. Shiferman, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 8/3/2020. (nms)
July 31, 2020 Filing 13 ANSWERING BRIEF in Opposition re #8 MOTION to Dismiss for Lack of Subject Matter Jurisdiction or, in the Alternative, Under the Two Dismissal Rule filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..Reply Brief due date per Local Rules is 8/7/2020. (Brauerman, Stephen)
July 22, 2020 Pro Hac Vice Attorney Jonathan Herstoff for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
July 22, 2020 Pro Hac Vice Attorney Edgar H. Haug for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
July 22, 2020 Pro Hac Vice Attorney Porter F. Fleming for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
July 22, 2020 Pro Hac Vice Attorney Camille Y. Turner for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
July 22, 2020 Opinion or Order SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff, and Camille Y. Turner of Haug Partners LLP, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 7/22/2020. (nms)
July 21, 2020 Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, Jonathan Herstoff, and Camille Y. Turner of Haug Partners LLP - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
July 17, 2020 Filing 11 NOTICE of Appearance by Thatcher A. Rahmeier on behalf of Takeda Pharmaceuticals U.S.A., Inc. (Rahmeier, Thatcher)
July 17, 2020 Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceutical International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
July 17, 2020 Filing 9 OPENING BRIEF in Support re #8 MOTION to Dismiss for Lack of Subject Matter Jurisdiction or, in the Alternative, Under the Two Dismissal Rule, filed by Takeda Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 7/31/2020. (DiGiovanni, Francis) Modified on 7/17/2020 (nms).
July 17, 2020 Filing 8 MOTION to Dismiss for Lack of Subject Matter Jurisdiction or, in the Alternative, Under the Two Dismissal Rule - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis) Modified on 7/17/2020 (nms).
June 26, 2020 Filing 7 SUMMONS Returned Executed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. Takeda Pharmaceuticals U.S.A., Inc. served on 6/26/2020, answer due 7/17/2020. (Brauerman, Stephen)
June 17, 2020 Filing 6 REDACTED VERSION of #2 Complaint, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen)
June 17, 2020 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
June 11, 2020 Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Brauerman, Stephen)
June 11, 2020 Opinion or Order Filing 4 ORDER Granting #1 MOTION For Leave to File Complaint Under Seal. Signed by Judge Richard G. Andrews on 6/11/2020. (nms)
June 11, 2020 Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak)
June 11, 2020 Filing 2 [SEALED] COMPLAINT for Declaratory Judgment - filed against Takeda Pharmaceuticals U.S.A., Inc. (Filing fee $ 400, receipt number ADEDC-2987737) - filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet) (lak) Modified on 6/17/2020 (nms).
June 11, 2020 Filing 1 MOTION for leave to file Complaint under Seal - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. (Attachments: #1 Text of Proposed Order) (lak)
June 11, 2020 Remark: Case submitted for routine judicial assignment. (lak)
June 11, 2020 Remark: Exit electronic copies to Duty Judge (RGA). (lak)
June 11, 2020 No Summons Issued. (lak)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Dr. Reddy's Laboratories, Ltd. v. Takeda Pharmaceuticals U.S.A., Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Dr. Reddy's Laboratories, Inc.
Represented By: Stephen B. Brauerman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Dr. Reddy's Laboratories, Ltd.
Represented By: Stephen B. Brauerman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Takeda Pharmaceuticals U.S.A., Inc.
Represented By: Edgar H. Haug
Represented By: Thatcher A. Rahmeier
Represented By: Porter F. Fleming
Represented By: Camille Y. Turner
Represented By: Jonathan Herstoff
Represented By: Francis DiGiovanni
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?